mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.1 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
UNC0638 |
GDSC1000 |
pan-cancer |
AAC |
0.043 |
0.1 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.077 |
0.1 |
mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.1 |